AbCellera Beat Consensus Estimates
Thursday, May 8, 2025 at 4:05 PM ET
AbCellera (ABCL) reported a loss of $0.15 per share on revenue of $4.24 million for the first quarter ended March 2025. The consensus estimate was a loss of $0.17 per share on revenue of $11.27 million. The company beat consensus estimates by 11.76% while revenue fell 57.45% compared to the same quarter a year ago.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.
Earnings Whisper Grade
Power Rating
-
-
Reported Earnings
$-0.15
Earnings Whisper®
-
Consensus Estimate
$-0.17
Earnings Surprise
Earnings Growth
Reported Revenue
$4.24 Mil
Revenue Estimate
$11.27 Mil
Revenue Surprise
Revenue Growth